Theravance Biopharma Inc (TBPH)
Investing Cash Flow
-$60.40M
Quarterly · Period ending: · USD
TBPH Investing Cash Flow
Latest reported-$60.40Mperiod ending
Latest reported-$60.40Mperiod ending
TBPH Quarterly Cash from Investing (-$467.00K → -$60.40M)
Quarterly investing cash flow
High-resolution chart · PNG
TBPH investing cash flow history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Investing Cash Flow (USD) |
|---|---|
| -60,403,000 | |
| 52,593,000 | |
| 588,000 | |
| -100,246,000 | |
| -36,258,000 | |
| 30,632,000 | |
| 15,686,000 | |
| -17,399,000 | |
| -3,031,000 | |
| 17,028,000 | |
| -677,000 | |
| -21,000 | |
| 11,047,000 | |
| -43,046,000 | |
| 39,161,000 | |
| 1,075,409,000 | |
| 7,515,000 | |
| 31,924,000 | |
| 10,824,000 | |
| -35,793,000 | |
| 35,766,000 | |
| 113,697,000 | |
| 52,403,000 | |
| 66,539,000 | |
| -176,590,000 | |
| 68,403,000 | |
| 14,061,000 | |
| -23,656,000 | |
| -1,296,000 | |
| -72,160,000 | |
| 99,393,000 | |
| 46,647,000 | |
| 41,962,000 | |
| -11,294,000 | |
| 41,250,000 | |
| 14,763,000 | |
| 11,176,000 | |
| -123,522,000 | |
| -46,205,000 | |
| -49,840,000 | |
| -68,575,000 | |
| 16,385,000 | |
| -34,503,000 | |
| 62,089,000 | |
| 41,299,000 | |
| 42,154,000 | |
| 9,684,000 | |
| -109,856,000 | |
| -4,459,000 | |
| -1,620,000 | |
| -1,066,000 | |
| -237,000 | |
| -691,000 | |
| -640,000 | |
| -261,000 | |
| -467,000 |